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Diet and diabetes
iabetes mellitus is expected to be the leading cause of 
chronic disease in Australia by 2023. Being overweight 
or obese carries significant risks for developing type 2 
diabetes mellitus (T2DM). Lifestyle modification remains the 
bedrock of management of T2DM and its related comorbidities 
in Australian and international treatment guidelines.1,2 Once 
T2DM develops, the combination of diet, lifestyle changes and 
physical activity has a major impact on glycaemic control, weight 
management and complication prevention. 
The role of diet in diabetes prevention 
It is estimated that 16.4% of Australians have prediabetes.3 
This is defined as impaired fasting glucose (IFG) and impaired 
glucose tolerance, or an HbA1c of 6.0–6.4% (42– 46 mmol/
mol).4 Prediabetes carries an independent risk for cardiovascular 
disease, separate from the risks of developing T2DM.3  Thus, 
prediabetes risk prevention must address the prevention 
of cardiovascular risks as much as managing progressive 
dysglycaemia.3 
Most diabetes prevention studies (Table 1) included dietary 
components to the intervention. Changes in levels of physical 
activity and, in some cases, addition of pharmacological 
interventions, make it difficult to define the independent 
effect of dietary changes in the prevention of type 2 diabetes.5 
However, of the dietary changes used in these studies, the 
Finnish Diabetes Prevention Study6 gives some insights. Rates of 
diabetes risk reduction were highest in people who achieved the 
greatest adherence to: 
• weight reduction >5% 
• fat intake <30% of total energy intake 
• saturated fat intake <10% of total energy intake 
• dietary fibre intake ≥15 g/1000 kcal 
• at least moderate intensity exercise for >4 hours weekly.
Background
Guidelines for the prevention and management of type 2 
diabetes mellitus (T2DM) reinforce lifestyle management, yet 
advice to guide general practitioners on principles around 
dietary choices is needed. 
Objective
This article provides current evidence regarding the differing 
diets in diabetes prevention and management once T2DM 
arises, including the role in management of complications such 
as hypoglycaemia. 
Discussion
Diets should incorporate weight maintenance or loss, while 
complementing changes in physical activity to optimise 
the metabolic effects of dietary advice. Using a structured, 
team-care approach supports pragmatic and sustainable 
individualised plans, while incorporating current evidence-
based dietary approaches. 
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From the intervention over 6 years, the relative risk reduction 
in progression to diabetes was 31% in the diet group, 46% in the 
exercise group and 42% in the combination group, suggesting 
that an appropriate strategy of physical activity and/or dietary 
changes aimed at promoting weight loss can prevent diabetes. 
It is estimated that weight loss of 5 kg in all people who are 
overweight or obese would reduce the national prevalence of 
T2DM by 15%.7 
When dietary saturated fats are decreased and replaced 
by polyunsaturated fatty acids (PUFAs) there are significant 
reductions in the risks of developing diabetes.8 Additionally, 
a recent study analysing the independent effect of the 
Mediterranean diet on prediabetes development9 showed that 
this diet supplemented with extra virgin olive oil reduced the 
development of prediabetes by 40%, compared with a control 
diet.
The National Health and Medical Research Council (NHMRC) 
Australian Dietary Guidelines 20137 assesses the effects of diet 
on diabetes prevention. Consumption of sugar-sweetened drinks 
increases the risk of developing T2DM. Consumption of cereal 
foods (especially three serves a day of wholegrains) is associated 
with reduced risk of T2DM. This evidence supports three serves 
per day of wholegrain foods conferring a risk reduction of 
21–42%. In some people, consumption of four cups of coffee per 
day reduces the risk of diabetes through unknown mechanisms. 
Two to four serves of dairy foods (milk, cheese, yoghurt) per 
day is associated with reduced risk of metabolic syndrome and 
consumption of at least 1.5 serves of milk, cheese and yoghurt 
per day is associated with reduced risk of T2DM. 
Cardiovascular risk reduction is imperative in prediabetes 
and, as such, the Mediterranean diet seems to have the best 
overall evidence of long-term effects on cardiovascular risk 
reduction.8,10–14
Dietary management when patients 
develop T2DM 
The most successful nutritional strategy for prevention and 
treatment of T2DM is one that is individualised, that takes into 
consideration culture, food availability and personal preferences, 
but follows recommendations that encourage a variety of foods 
from the five main food groups each day. Australian guidelines7 
give similar advice for diabetes prevention, recommending that 
saturated fats should be minimised. Conversely, dietary fat 
quantity or quality has minimal direct influence on glycaemic 
control but may contribute to metabolic effects such as weight 
gain and obesity, which may affect glycaemic control in the longer 
term. 
Extreme dietary restriction and avoidance of certain food 
groups, such as very low dairy or grain-free diets, might achieve 
short-term weight loss but do not represent a sustainable 
balanced diet plan. Ideally, the diet should be sustainable and be 
able to be maintained over the long term to provide adequate 
amounts of nutrients and kilojoules to maintain ideal weight, help 
stabilise blood glucose levels and assist in the maintenance of an 
optimal lipid profile.
Dietary advice should address intake of fruit and vegetables, 
unrefined grains with natural high-fibre content, vegetable 
oils with low content of saturated fat (such as olive oil), nuts, 
legumes, low-fat dairy and fish as sources of protein, and limit the 
intake of highly processed foods.15
Weight management should be a priority, particularly visceral 
fat reduction, in those who are overweight or obese. Visceral 
Table 1. A summary of diabetes prevention studies
Study Number of 
participants
Intervention Treatment Risk reduction
Da Qing IGT and Diabetes 
Study27
577 Diet and exercise 6 years, 
follow-up at 20 years 
34–69%
Finnish Diabetes Prevention 
Study6
522 Diet and exercise 3 years, 




3234 Diet, exercise and 
metformin 
2.8 years, 
follow-up at 10 years
31–58%
Indian Diabetes Prevention 
Programme29
531 Diet, exercise and 
metformin
3 years 26.4–28.4%
Predimed9 3541 Mediterranean diet  
with:
• EVOO*
• nuts versus control  
diet
4 years • 40% 
• 18% 
Prediabetes as a 
secondary endpoint
*EVOO, extra virgin olive oil
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adiposity (and its accompanying inflammatory processes) 
contributes to significantly increased insulin resistance and 
complication progression. 
Physical activity acts independently and synergistically with 
attempts to control weight regain achieved through nutritional 
interventions. Total reduction of kilojoule intake achieves this aim, 
independently of the macronutrient component of the diet. 
The NHMRC Australian Dietary Guidelines 2013 has a pictorial 
guide to assist with the education of patients. 
Guiding patients to make a choice
Use of the 5As approach (Ask, Assess, Advise, Assist and 
Arrange),16,17 will allow the general practitioner (GP) to adopt 
a plan that considers individual, cultural and lifestyle factors in 
guiding food choices, using a team-based approach to dietary 
support, including the use of a dietician, exercise physiologist and 
specialist care services (eg for a very low energy diet or bariatric 
surgery pre- and post-surgical care). These principles are further 
explained in the Royal Australian College of General Practitioners’ 
Smoking, nutrition, alcohol, physical activity (SNAP) guidelines.17 
Various popular dietary approaches
Mediterranean diet 
A Mediterranean diet is one that comprises at least two of the 
following components:13
• high monounsaturated:saturated fat ratio
• low-to-moderate red wine consumption
• high consumption of legumes
• high consumption of grains and cereals
• high consumption of fruits and vegetables
• low consumption of meat and meat products and increased 
consumption of fish
• moderate consumption of milk and dairy products. 
A kilojoule-reduced Mediterranean diet may achieve weight 
loss and may show improvement in blood pressure control and 
triglyceride levels. The benefit of a Mediterranean diet is that it is 
flexible and can suit a vegan, vegetarian or meat-eater. 
Low carbohydrate diets 
These diets have different descriptions in clinical trials, making 
broad judgments of their effectiveness difficult. Examples include:
• low-carbohydrate ketogenic diet (LCKD): <50 g of 
carbohydrates (10% kilojoules) daily
• low-carbohydrate diet (LCD): 50–130 g carbohydrates (10–26% 
of kilojoules) daily 
• moderate carbohydrate diet (MCD): 130–225g carbs daily 
(26–45% of kilojoules) daily.
Across this range, however, the effects on improved 
glycaemia and weight reduction may be mainly due to kilojoule 
restriction.18–20 Longer term studies have not revealed any 
prolonged superiority of these diets in complication risk reduction 
and short-term studies have not revealed any risk increase.19,20
Intermittent or alternate day fasting versus 
continual calorie restriction (CCR) 
Despite the popularity of the 5:2 diet, a review21 has found no 
meaningful differences in glucose control. There was more 
weight loss with CCR but each diet produced comparable 
reductions in visceral fat weight. The authors concluded that 
more research is needed to see if there are benefits specific 
to T2DM. Significantly, fasting may need careful assessment 
to avoid hypoglycaemia in patients on oral sulphonylureas or 
insulins. 
Very low energy diets (VLED) 
Very low-energy diets may be a useful intensive intervention that 
is effective in achieving weight loss. According to the NHMRC 
guidelines,16 VLED may be considered in adults with a BMI 
>30 kg/m2, or with a BMI >27 kg/m2 and T2DM. Rather than 
self-management, referral to specialist care services would be 
recommended for this approach. 
Low glycaemic index diet 
The effect of foods with a low glycaemic index has been 
studied in T2DM22 and there is some evidence for benefit 
through a reduction in HbA1c levels of up to 0.5% and fewer 
hypoglycaemic events. However, this dietary approach did not 
achieve additional weight loss, compared with high glycaemic 
index or load diets. 
Alcohol
Given the additive effects of alcohol and hypoglycaemia on 
behaviour and cognitive function, it is recommended that people 
with diabetes not consume alcohol when driving. Alcohol may 
aggravate accompanying comorbidities, including liver disease 
and neuropathy – so adherence to the Australian Alcohol 
guidelines23 is advisable, as is discussion with the diabetes health 
professional team members. 
Low kilojoule sweeteners
A meta-analysis of multiple trials24 showed a small amount of 
weight loss with the use of low-kilojoule sweeteners. Use of 
such sweeteners could be helpful for weight maintenance for 
patients with T2DM, but there is a lack of evidence that they may 
assist in preventing complications of T2DM.
Patients using insulin 
The total carbohydrate intake at a meal correlates closely with 
postprandial glycaemia, but improving glycaemic control by 
limiting the carbohydrate intake alone has not been supported 
by high-quality studies.25 However, understanding the patterns of 
carbohydrate consumption and self-monitoring of blood glucose 
(SMBG) may be helpful for patients using mealtime or prandial 
rapid-acting insulin, as suggested in UK guidelines.25 In patients 
with unstable T2DM on insulin, the use of low carbohydrate 
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dietary approaches, including ketogenic diets, may cause 
hypoglycaemia, complicating the matching of glucose self-
monitoring to medical supervision of insulin dose adjustment. 
Diet and hypoglycaemia1
If the blood glucose levels (BGL) is <4.0 mmol/L and the patient 
is symptomatic, awake and can swallow, manage according to 
the Rule of 15:1
• Provide 15 g of quick-acting carbohydrate that is easy to 
consume (eg half a can of regular (non-diet) soft drink, half 
a glass of fruit juice, 3 teaspoons of sugar or honey, 6–7 
jellybeans, 3 glucose tablets).
• Wait 15 minutes and repeat blood glucose check. If the level 
is not rising, suggest eating another quick-acting carbohydrate 
from the above list.
• If the patient’s next meal is more than 15 minutes away, 
provide some longer acting carbohydrate (eg a sandwich, 
1 glass of milk or soy milk, 1 piece of fruit, 2–3 pieces of 
dried apricots, figs or other dried fruit, 1 tub of natural low-fat 
yoghurt, 6 small dry biscuits and cheese).
• Test glucose again during the next 2–4 hours.
Diet and nephropathy 
A meta-analysis26 of 13 randomised trials involving 779 
patients showed some evidence that a lowered protein diet 
assisted with diabetic nephropathy, when patients adhered 
to this diet. Management of hypertension through the use 
of pharmacotherapy and a sodium restricted diet, in addition 
to tight glycaemic and lipid control underpin the long-term 
prevention of this condition. 
Summary 
What is the ideal diet for prevention and the management of 
T2DM? It remains an individualised, sustainable dietary plan 
that achieves and maintains an ideal weight range, while 
addressing major comorbidities such as cardiovascular disease. 
Differing dietary approaches to kilojoule restriction, (including 
VLED approaches) act synergistically with increasing physical 
activity to help address weight management. Of all approaches, 
the Mediterranean diet has accumulated evidence showing 
cardiovascular risk reduction. Implementing a structured approach 
using a 5As, team-based approach will allow a GP to provide a 
supportive framework to integrate these principles to support the 
increasing number of identified patients needing dietary advice. 
Authors
Gary Deed MBBS FACNEM MRACGP, Chair of the Diabetes Specific Interest 
Network RACGP and General Practitioner, Coorparoo, QLD. g.deed@uqconnect.
net
John Barlow MBBS MRCGP, General Practitioner, Bankstown, NSW
Dev Kawol MBBS, FRACGP DRCOG DFSRH MSc Diab, General Practioner, 
Brookwater General Practice, Brookwater, QLD
Gary Kilov MBBCh, Director, Seaport Practice, Launceston, TAS
Anita Sharma MBBS FRACGP, Practice Principal, Platinum Medical Centre, 
Chermside, QLD
Liew Yu Hwa MBBS, FRACGP, MMed (Skin Cancer), General Practitioner, 
Tweed City Family Practice, Tweed Head, NSW and Albert Street Medical 
Centre, Logan Village, QLD
Competing interests: Gary Deed has received consultancy fees from 
Novo Nordisk, Eli Lilly, Sanofi, Janssen, MSD, Roche Accucheck, Takeda 
Pharmaceuticals Australia, Novartis Pharmaceuticals, AstraZeneca Australia, 
the Royal Australian College of General Practitioners and the Obesity Australia 
Summit. He has also received payment for the development of educational 
presentations from all of the pharmaceutical companies named above. 
John Barlow has acted in a consultancy capacity for, is a member of the 
advisory boards for and has received payment from multiple pharmaceutical 
companies including Eli Lilly, Sanofi, AstraZeneca Australia, Mylan and Novartis 
Pharmaceuticals. He has also been paid by medical education companies in 
relation to the development of educational presentations. Anita Sharma and 
Gary Kilov have, in relation to this article, worked with the Insulin Leadership 
Summit faculty at Sanofi. They have also, outside this work, received 
payment for board membership and educational presentations from Sanofi, 
AstraZeneca, Novartis, Roche Accu-Chek, Boehringer Ingelheim, Lilly Diabetes, 
Novo Nordisk, Takeda, Janssen and MSD; and have been paid by various 
agencies to attend board and consultancy meetings. 
Provenance and peer review: Commissioned, externally peer reviewed.
References
1. The Royal Australian College of General Practitioners, Diabetes Australia. 
General practice management of type 2 diabetes. Appendix J: glycaemic 
emergencies. Melbourne: RACGP, 2014. Available at www.racgp.org.au/
download/Documents/Guidelines/Diabetes/2014diabetesmanagement.pdf 
[Accessed 27 March 2015].
2. Innucchi E, Bergenstal R, Buse J, et al. Management of hyperglycaemia in 
type 2 diabetes, 2015: a patient centered approach. Update to a Position 
Statement of the American Diabetes Association and the European Asso-
ciation for the Study of Diabetes. Diabetes Care 2015;38:140–49.
3. Twigg S, Kamp M, Davis T, et al. Prediabetes: a position statement from 
the Australian Diabetes Society and Australian Diabetes Educators Associ-
ation. Med J Aust 2007;186:461–65.
4. Morris DH, Khunti K, Achana F, et al. Progression rates from HbA 1c 
6.0–6.4% and other prediabetes definitions to type 2 diabetes: a me-
ta-analysis. Diabetologia 2013;56:1489–93.
5. Dunkley A, Bodicoat D, Greaves C, et al. Diabetes prevention in the real 
world: effectiveness of pragmatic lifestyle interventions for the prevention 
of type 2 diabetes and of the impact of adherence to guideline recom-
mendations. A systematic review and meta-analysis. Diabetes Care 
2014;37:922–33.
6. Lindstrom J, Louheranta A, Manellin M, et al. Strategies for preventing 
type 2 diabetes: an update for clinicians. The Finnish Diabetes Prevention 
Study (DPS) Lifestyle intervention and 3-year results on diet and physical 
activity. Diabetes Care 2003;26:3230–36.
7. National Health And Medical Research Council. Australian Dietary 
Guidelines. Providing the scientific evidence for healthier Australian diets 
2013. Available at https://www.nhmrc.gov.au/guidelines-publications/n55 
[Accessed 27 March 2015].
8. Panagiotakos DB, Georgousopoulou EN, Pitsavos C, et al. Exploring the path 
of Mediterranean diet on 10-year incidence of cardiovascular disease: The 
ATTICA study (2002–2012). Nutr Metab Cardiovasc Dis 2015;25:327–35.
9. Salas-Salvadó J, Bulló M, Estruch R, et al. Prevention of diabetes with 
Mediterranean diets: a subgroup analysis of a randomized trial. Ann Intern 
Med 2014;160:1–10.
10. Huo R, Du T, Xu Y, et al. Effects of Mediterranean-style diet on glyce-
mic control, weight loss and cardiovascular risk factors among type 2 
diabetes individuals: a meta-analysis. Eur J Clin Nutr 2014; doi:10.1038/
ejcn.2014.243.
11. Ajala O, English P, Pinkney J. Systematic review and meta-analysis of 
different dietary approaches to the management of type 2 diabetes. Am J 
Clin Nutr 2013;97:505–16.
12. Koloverou E, Esposito K, Giugliano D, Panagiotakos DB. The effect of 
Mediterranean diet on the development of type 2 diabetes mellitus: a me-
ta-analysis of 10 prospective studies and 136,846 participants. Metabolism 
2014;63:903–11.
292
FOCUS  DIET AND DIABETES
REPRINTED FROM AFP VOL.44, NO.5, MAY 2015
13. Rees K, Hartley L, Flowers N, et al. ‘Mediterranean’ dietary pattern for the 
primary prevention of cardiovascular disease. Cochrane Database Syst Rev 
2013;8:CD009825.
14. Martinez-Gonzalez MA, De La Feunte-Arrillaga C, Nunez- Corboba JM, 
et al. Adherence to Mediterranean diet and risk of developing diabetes: 
prospective cohort study BMJ 2008;336:1348.
15. Portero Mclellan KC, Wyne K, Villagomez ET, Hsueh WA. Therapeutic 
interventions to reduce the risk of progression from prediabetes to type 2 
diabetes mellitus. Ther Clin Risk Manag 2014;10:173–88.
16. National Health and Medical Research Council. Clinical practice guidelines 
for the management of overweight and obesity in adults, adolescents and 
children in Australia. Available at www.nhmrc.gov.au/_files_nhmrc/publi-
cations/attachments/n57_obesity_guidelines_131204_0.pdf [Accessed 27 
March 2015].
17. Royal Australian College of General Practitioners. Smoking, nutrition, 
alcohol, physical activity (SNAP). 2nd edn. Melbourne: RACGP, 2015. 
Available at www.racgp.org.au/download/Documents/Guidelines/snap.pdf 
[Accessed 27 March 2015].
18. Hu T, Mills KT, Yao L. Effects of low-carbohydrate diets versus low-fat diets 
on metabolic risk factors: a meta-analysis of randomized controlled clinical 
trials. Am J Epidemiol 2012;176:S44–54.  
19. Santos FL, Esteves SS, Da Costa Pereira A, et al. Systematic review and 
meta-analysis of clinical trials of the effects of low carbohydrate diets on 
cardiovascular risk factors. Obes Rev 2012;13:1048–66.  
20. Schwingshackl L, Hoffmann G. Long-term effects of low-fat diets either 
low or high in protein on cardiovascular and metabolic risk factors: a sys-
tematic review and meta-analysis. Nutr J 2013;12:48.
21. Barnosky AR, Hoddy KK, Unterman TG, Varady KA. Intermittent fasting vs 
daily calorie restriction for type 2 diabetes prevention: a review of human 
findings. Transl Res 2014;164:302–11. 
22. Thomas D, Elliot EJ. Low glycaemic index, or low glycaemic load, diets for 
diabetes mellitus. Cochrane Database Syst Rev 2009;(1):CD006296.
23. Australian Government Department of Health. Australian guidelines to 
reduce health risks from drinking alcohol. Canberra: Commonwealth of 
Australia, Available at www.alcohol.gov.au/internet/alcohol/publishing.nsf/
Content/guidelines [Accessed 27 March 2015].
24. Miller PE, Perez V. Low-calorie sweeteners and body weight and composi-
tion: a meta-analysis of randomized controlled trials and prospective cohort 
studies. Am J Clin Nutr 2014;100:765–77.
25. Kelly T, Dyson P, editors. Evidence-based nutrition guidelines for the 
prevention and management of diabetes. London: Diabetes UK, 2011. 
Available at www.diabetes.org.uk/documents/reports/nutritional_guide-
lines200911.pdf [Accessed 27 March 2015].
26. Nezu U, Kamiyama H, Kondo Y, et al. Effect of low-protein diet on kidney 
function in diabetic nephropathy: meta-analysis of randomised controlled 
trials. BMJ Open 2013;3:e002934.
27. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing 
NIDDM in people with impaired glucose tolerance. The Da Qing IGT and 
Diabetes Study. Diabetes Care 1997;20:537–44.
28. Knowler W, Barrett-Connor E, Fowler S, et al. Reduction in the incidence 
of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 
2002;346:393–403.
29. Ramachandran A, Snehalatha C, Mary S, et al. The Indian Diabetes Preven-
tion Programme shows that lifestyle modification and metformin prevent 
type 2 diabetes in Asian Indian subjects with impaired glucose tolerance 
(IDPP-1). Diabetologia 2006;49:289–97. 
